We are live on ! Find out more

OSIR

Osiris Therapeutics, Inc. Common Stock

OSIR

Delisted

OSIR was delisted on the 16th of April, 2019.

32 hedge funds and large institutions have $29.6M invested in Osiris Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 32 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New

Increased

Maintained

Reduced

Closed

25,412% more capital invested

Capital invested by funds: $116K → $29.6M (+$29.5M)

3,100% more funds holding

Funds holding: 1 → 32 (+31)

3,100% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 1

Holders

Holders Change

+31

Holders Change %

+3,100%

% of All Funds

0.73%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

–

Reduced

–

Closed

Calls

–

Puts

–

Net Calls

–

Net Calls Change

–

Top Buyers

Rank	Fund	Capital Flow
1	Vanguard Group Malvern, Pennsylvania	+$7.15M
2	Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada	+$6.42M
3	GF Gabelli Funds Rye, New York	+$4.61M
4	Susquehanna International Group Bala Cynwyd, Pennsylvania	+$1.37M
5	Geode Capital Management Boston, Massachusetts	+$1.08M

Top Sellers

Rank	Fund	Capital Flow
1	Public Employees Retirement Association of Colorado Denver, Colorado	-$116K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	1 Vanguard Group Malvern, Pennsylvania	$7.94M	+$7.15M	+715,016	New
2	2 Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada	$7.12M	+$6.42M	+641,224	New
3	GF 3 Gabelli Funds Rye, New York	$5.11M	+$4.61M	+460,389	New
4	4 Susquehanna International Group Bala Cynwyd, Pennsylvania	$1.52M	+$1.37M	+137,298	New
5	5 Geode Capital Management Boston, Massachusetts	$1.2M	+$1.08M	+107,874	New
6	QI 6 QS Investors New York	$1.17M	+$1.06M	+105,759	New
7	7 Northern Trust Chicago, Illinois	$1.01M	+$907K	+90,605	New
8	GI 8 GAMCO Investors Greenwich, Connecticut	$777K	+$700K	+69,999	New
9	BRF 9 B. Riley Financial Los Angeles, California	$578K	+$521K	+52,110	New
10	DAM 10 Deltec Asset Management New York	$555K	+$500K	+50,000	New
11	11 Renaissance Technologies New York	$351K	+$317K	+31,640	New
12	MIM 12 Monashee Investment Management Boston, Massachusetts	$333K	–	–	–
13	CLOS 13 Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland	$333K	+$300K	+29,992	New
14	14 Deutsche Bank Frankfurt Am Main Ge, Germany	$290K	+$262K	+26,140	New
15	15 JP Morgan Chase New York	$260K	+$234K	+23,383	New
16	HK 16 Horizon Kinetics New York	$211K	+$190K	+19,000	New
17	17 Millennium Management New York	$194K	+$175K	+17,511	New
18	18 SG Americas Securities New York	$141K	+$127K	+12,693	New
19	19 Bank of New York Mellon New York	$114K	+$102K	+10,227	New
20	CG 20 Caprock Group Boise, Idaho	$111K	+$100K	+10,000	New
21	21 UBS Group Zurich, Switzerland	$69K	+$62.2K	+6,217	New
22	WSTAM 22 Wilbanks Smith & Thomas Asset Management Norfolk, Virginia	$61K	+$55K	+5,500	New
23	23 Bank of America Charlotte, North Carolina	$55K	+$49.2K	+4,914	New
24	24 Wells Fargo San Francisco, California	$36K	+$32K	+3,200	New
25	25 Royal Bank of Canada Toronto, Ontario, Canada	$33K	+$30K	+3,000	New

OSIR Hedge Fund Activity: Q3 2018 in Review

32 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q3 2018, worth a combined $29.6M — up 25,412% from $116K a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new OSIR positions and 1 closed out — a net gain of 31 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $7.15M. The largest seller was Public Employees Retirement Association of Colorado, exiting entirely with an estimated $116K sold.

32 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q3 2018, up from 1 in Q2 2018.
Funds reported $29.6M of Osiris Therapeutics, Inc. Common Stock stock for Q3 2018, up 25,412% quarter-over-quarter.
32 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q3 2018 and 1 closed out, a net change of +31 holders.
The largest Osiris Therapeutics, Inc. Common Stock buyer in Q3 2018 was Vanguard Group, an estimated $7.15M added.
The largest Osiris Therapeutics, Inc. Common Stock seller in Q3 2018 was Public Employees Retirement Association of Colorado, an estimated $116K sold.

Based on aggregated 13F filings for Q3 2018.

Osiris Therapeutics, Inc. Common Stock OSIR